SCM
MDT icon

Shelton Capital Management’s Medtronic MDT Stock Holding History

Shelton Capital Management’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.59M Sell
18,294
-156
-0.8% -$14.9K 0.03% 235
2025
Q4 		$1.77M Hold
18,450
– – 0.04% 230
2025
Q3 		$1.76M Sell
18,450
-244
-1% -$22.4K 0.04% 228
2025
Q2 		$1.63M Sell
18,694
-202
-1% -$17.1K 0.04% 240
2025
Q1 		$1.7M Sell
18,896
-85
-0.4% -$7.61K 0.04% 236
2024
Q4 		$1.52M Hold
18,981
– – 0.04% 245
2024
Q3 		$1.71M Buy
18,981
+1,908
+11% +$161K 0.04% 247
2024
Q2 		$1.34M Buy
17,073
+8,998
+111% +$738K 0.04% 264
2024
Q1 		$704K Sell
8,075
-200
-2% -$17.1K 0.02% 304
2023
Q4 		$682K Sell
8,275
-182
-2% -$13.9K 0.02% 295
2023
Q3 		$663K Hold
8,457
– – 0.02% 289
2023
Q2 		$745K Sell
8,457
-319
-4% -$27.5K 0.03% 286
2023
Q1 		$707K Buy
8,776
+521
+6% +$42.5K 0.03% 263
2022
Q4 		$642K Sell
8,255
-2,742
-25% -$222K 0.07% 244
2022
Q3 		$888K Hold
10,997
– – 0.04% 251
2022
Q2 		$987K Sell
10,997
-46
-0.4% -$4.66K 0.04% 257
2022
Q1 		$1.23M Hold
11,043
– – 0.05% 256
2021
Q4 		$1.14M Sell
11,043
-126
-1% -$14.6K 0.04% 262
2021
Q3 		$1.4M Sell
11,169
-137
-1% -$17.7K 0.05% 250
2021
Q2 		$1.4M Buy
11,306
+267
+2% +$33.5K 0.05% 252
2021
Q1 		$1.3M Sell
11,039
-385
-3% -$45.1K 0.05% 273
2020
Q4 		$1.34M Sell
11,424
-4,798
-30% -$528K 0.06% 241
2020
Q3 		$1.69M Sell
16,222
-62,699
-79% -$6.3M 0.07% 282
2020
Q2 		$7.24M Sell
78,921
-3,954
-5% -$379K 0.4% 51
2020
Q1 		$7.47M Buy
82,875
+1,600
+2% +$170K 0.54% 36
2019
Q4 		$9.22M Buy
81,275
+25,265
+45% +$2.77M 0.51% 45
2019
Q3 		$6.08M Buy
56,010
+8,874
+19% +$926K 0.36% 59
2019
Q2 		$4.59M Buy
47,136
+45,903
+3,723% +$4.19M 0.26% 75
2019
Q1 		$13.5K Sell
1,233
-12,303
-91% -$1.1M 0.05% 298
2018
Q4 		$1.23M Hold
13,536
– – 0.08% 195
2018
Q3 		$1.33M Sell
13,536
-195
-1% -$18K 0.08% 210
2018
Q2 		$1.18M Buy
13,731
+495
+4% +$41.3K 0.07% 221
2018
Q1 		$1.06M Hold
13,236
– – 0.07% 225
2017
Q4 		$1.07M Hold
13,236
– – 0.07% 227
2017
Q3 		$1.03M Sell
13,236
-32
-0.2% -$2.66K 0.07% 236
2017
Q2 		$1.18M Sell
13,268
-187
-1% -$15.8K 0.08% 205
2017
Q1 		$1.08M Sell
13,455
-100
-0.7% -$7.81K 0.08% 215
2016
Q4 		$966K Buy
13,555
+100
+0.7% +$7.86K 0.07% 241
2016
Q3 		$1.16M Buy
13,455
+91
+0.7% +$7.93K 0.1% 190
2016
Q2 		$1.16M Buy
13,364
+2,003
+18% +$162K 0.1% 182
2016
Q1 		$852K Buy
11,361
+300
+3% +$22.6K 0.08% 225
2015
Q4 		$851K Buy
11,061
+125
+1% +$9.41K 0.08% 219
2015
Q3 		$732K Hold
10,936
– – 0.08% 234
2015
Q2 		$810K Hold
10,936
– – 0.08% 223
2015
Q1 		$853K Buy
10,936
+3,376
+45% +$256K 0.09% 220
2014
Q4 		$546K Sell
7,560
-300
-4% -$20.8K 0.06% 332
2014
Q3 		$487K Sell
7,860
-200
-2% -$12.7K 0.07% 345
2014
Q2 		$514K Sell
8,060
-2,200
-21% -$134K 0.07% 334
2014
Q1 		$631K Buy
10,260
+300
+3% +$17.5K 0.09% 248
2013
Q4 		$572K Sell
9,960
-2,500
-20% -$142K 0.09% 266
2013
Q3 		$663K Buy
12,460
+4,900
+65% +$264K 0.11% 190
2013
Q2 		$389K Buy
+7,560
New +$374K 0.07% 351

Other funds holding MDT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Shelton Capital Management's MDT Position: Q1 2026 in Review

Shelton Capital Management reduced its Medtronic (MDT) stake by 0.85% in Q1 2026, selling an estimated $14.9K and leaving 18,294 shares worth $1.59M. The position accounts for 0.03% of the portfolio, ranked #235.

Shelton Capital Management first reported a position in MDT in Q2 2013 and has held it in 52 quarters since. The position peaked at $9.22M in Q4 2019. 2,231 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Shelton Capital Management held 18,294 shares of Medtronic worth $1.59M as of Q1 2026.
  • Shelton Capital Management sold 156 Medtronic shares in Q1 2026, an estimated $14.9K.
  • Medtronic made up 0.03% of Shelton Capital Management's portfolio in Q1 2026, its #235 holding.
  • Shelton Capital Management first reported a position in Medtronic in Q2 2013 and has held it in 52 quarters since.
  • Shelton Capital Management's Medtronic position peaked at $9.22M in Q4 2019.
  • 2,231 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Shelton Capital Management's 13F filing for Q1 2026, filed 15 May 2026.